ScreenCell

ScreenCell was set-up with the belief that just enumerating Circulating Tumor Cells (CTCs) without easily characterizing them was not enough to allow the early detection of a disease and to potentially follow-up the cancer progression. So it designed and produced a simple but revolutionary technology allowing the fast and effective isolation of CTCs for a better cellular and molecular characterization, which is essential in cancer monitoring. This technology also contributes to the development of a new non-invasive approach to prenatal diagnosis. Screencell is dedicated to create technologies allowing CTC to become potential end points in future oncology therapeutic arsenals, by...

Oncology,liquide biospy,ctcs,circulating tumor cells,molecular biology,cytology,cancer,cancer cell,personalized medicine,cell culture,biotech,and medtech

Screencell operates in the Biotechnology research industry.

Screencell's revenue is 11m - 100m

Screencell has 11 - 50 employees.